These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19561634)

  • 21. Histopathology and cytopathology of cervical cancer.
    Jenkins D
    Dis Markers; 2007; 23(4):199-212. PubMed ID: 17627056
    [No Abstract]   [Full Text] [Related]  

  • 22. Presence of proliferating (MiB-1-positive) cells in cervical smears of women infected with HIV is associated with clinical outcome: a study of Brazilian women.
    Boon ME; van der Veen G; Barlow Y; Graudenz MS; Kok LP
    Diagn Cytopathol; 2001 Jun; 24(6):373-7. PubMed ID: 11391816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D;
    Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The HPV test in primary cervical cancer screening].
    Bergeron C
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S90-1. PubMed ID: 18984315
    [No Abstract]   [Full Text] [Related]  

  • 25. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada.
    Healey SM; Aronson KJ; Mao Y; Schlecht NF; Mery LS; Ferenczy A; Franco EL
    Sex Transm Dis; 2001 Dec; 28(12):694-700. PubMed ID: 11725224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer screening: state of the art.
    Singer A
    Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):39-64. PubMed ID: 7600729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward objective cervical cancer screening: maybe the eyes do have it.
    Stoler MH
    Am J Clin Pathol; 2010 Jul; 134(1):5-6. PubMed ID: 20551259
    [No Abstract]   [Full Text] [Related]  

  • 28. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the ALTS trial apply to the community-based practitioner?
    Monk BJ; Brewster WR
    Am J Obstet Gynecol; 2003 Jun; 188(6):1381-2. PubMed ID: 12824966
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Geographical distribution of human papillomavirus and their correlation with cytologic abnormalities in cervical lesions and with the age in a female population from Transylvania].
    Feticu L; Bocşan IS; Bondor CI; Boboş C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):291-8. PubMed ID: 23077911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection.
    Schneider A; Zahm DM; Kirchmayr R; Schneider VL
    Am J Obstet Gynecol; 1996 May; 174(5):1534-41. PubMed ID: 9065125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV testing in cervical screening.
    Cuzick J
    Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
    [No Abstract]   [Full Text] [Related]  

  • 34. Women with cervical cancer precursor lesions: a high-risk group for human papillomavirus (HPV)-related oropharyngeal cancer?
    Thomsen LT; Kjær SK
    Acta Oncol; 2019 Mar; 58(3):265-266. PubMed ID: 30821615
    [No Abstract]   [Full Text] [Related]  

  • 35. Frequency of cervical smear abnormalities within 3 years of normal cytology.
    Dyson RD
    Obstet Gynecol; 2000 Dec; 96(6):1026. PubMed ID: 11203354
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
    Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical disease in women referred to colposcopy following inadequate smears.
    Hollingworth J; Kotecha K; Dobbs SP; Shaw PA; Ireland D
    Cytopathology; 2000 Feb; 11(1):45-52. PubMed ID: 10714375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical HPV testing versus cytology.
    Burki TK
    Lancet Oncol; 2018 Aug; 19(8):e390. PubMed ID: 30017347
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing cervical cancer globally by acting locally: if not now, when?
    Gage JC; Castle PE
    J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
    [No Abstract]   [Full Text] [Related]  

  • 40. Inadequate cervical smear: what do we do?
    Phadnis SV; Doshi JS; Ogunnaike OO; Padwick ML; Sanusi FA
    Acta Obstet Gynecol Scand; 2005 May; 84(5):486-8. PubMed ID: 15842215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.